glp-1/gip agonist GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Understand GLP-1/GIP Dual Agonist Tirzepatide

Marks gained a scholarship to study medicine at the University of Oxford and then qualified as a doctor at St Thomas' Hospital in 1954

For example, extremely high doses of magnesium are more likely to cause diarrhea, while large doses of fiber without adequate fluid can actually worsen constipation and make stool harder to pass

PD clinical trials The neuroprotective effects of GLP-1RAs, particularly exenatide, seem to be more promising in PD

In addition, look for tools that let you cap sessions or set cooling-off periods without contacting support, because quick self-service controls can make a major difference in maintaining balance

doi: 10.1007/s40264-023-01392-3 [DOI] [PMC free article] [PubMed] [Google Scholar] 125.Iber H, Li-Masters T, Chen Q, Yu S, Morgan ET

10.1111/bph.15059 73 ZhangL.LiC.ZhangZ.ZhangZ.JinQ